| 8030-84-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• CAS: 8030-84-0
• 化学式: C6H8KMgO7
• 分子量: 255.53
• InChiKey: BQRTULGSBYPNAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.01
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  132
• 氢给体数：
  4
• 氢受体数：
  7

文献信息

• Dual Cation Dual Anion Coordination Complexes
  申请人：Walter Mary Ann

  公开号：US20100184866A1

  公开（公告）日：2010-07-22

  Compounds are provided herein which are coordination complexes of the formula, A x B y Cit 2 F z .mH 2 O, wherein A is a cation selected from certain IA or IIA metal ions in the Periodic Table; B is a cation selected from certain IIA metal ions and certain divalent d-block transition metal ions; A and B are different; “Cit” is tribasic citric acid anion; the stoichiometric ratio of x to y is equal or higher than 1.0 but lower than 8.0; m is 0-12; and z is selected such that electroneutrality is preserved. Compounds provided herein are useful to treat dietary deficiencies, osteoporosis, osteopenia, bone loss, and risk of bone loss, as well as other medical conditions involving the need for administration of the various ions. In addition, the compounds can be used as fluoride sources for dental use and to fluoridate water systems.

  本文提供的化合物是配位化合物，化学式为AxByCit2Fz.mH2O，其中A是周期表中某些IA或IIA金属离子中选择的阳离子；B是从某些IIA金属离子和某些二价d-块过渡金属离子中选择的阳离子；A和B是不同的；“Cit”是三碱性柠檬酸根离子；x到y的化学计量比大于或等于1.0但小于8.0；m为0-12；z被选择以保持电中性。本文提供的化合物可用于治疗膳食缺乏、骨质疏松症、骨质疏松症、骨质流失以及骨质流失风险，以及其他需要给予各种离子的医疗情况。此外，这些化合物可用作牙科用氟化物来源，用于氟化水系统。
• PRODUCTION OF POTASSIUM MAGNESIUM CITRATE AND ITS APPLICATIONS
  申请人：Paikin Michael

  公开号：US20110081456A1

  公开（公告）日：2011-04-07

  Provided is a magnesium rich composition including potassium, magnesium and citrate, a method for producing such a composition and food or nutritional product including the composition.

  提供了一种富含钾、镁和柠檬酸盐的镁质组合物，以及制备该组合物的方法和包括该组合物的食品或营养产品。
• Magnesium potassium citrate
  申请人：MISSION PHARMACAL COMPANY, INC.

  公开号：EP0380829A1

  公开（公告）日：1990-08-08

  A dual mineral salt consisting essentially of magnesium, potassium and citrate. A method for manufacturing the subject salt in a form having a bulk density ranging from about 1.0 g/cc to about 1.3 g/cc is also disclosed, and the use of the subject salt as a dietary supplement are also disclosed.

  一种主要由镁、钾和柠檬酸盐组成的双重矿物盐。此外，还公开了一种以体积密度介于约 1.0 g/cc 至约 1.3 g/cc 的形式制造该主题盐的方法，以及该主题盐作为膳食补充剂的用途。
• Dietary supplementation with potassium magnesium citrate
  申请人：MISSION PHARMACAL COMPANY, INC.

  公开号：EP0429157A2

  公开（公告）日：1991-05-29

  The use of potassium magnesium citrate in the manufacture of an orally administrable medicament. The medicament is used for supplementing dietary potassium, supplementing dietary magnesium, supplementing dietary citrate, increasing urinary citrate excretion, increasing urinary magnesium excretion, decreasing urinary calcium or decreasing urinary oxalate.

  使用柠檬酸钾镁制造口服药物。该药物用于补充膳食中的钾、膳食中的镁、膳食中的柠檬酸盐、增加尿液中柠檬酸盐的排泄、增加尿液中镁的排泄、降低尿液中钙的含量或降低尿液中草酸盐的含量。
• NUTRITIONAL COMPOSITIONS FOR THE MANAGEMENT OF GLUCOSE METABOLISM
  申请人：Dialpha

  公开号：EP3235510A1

  公开（公告）日：2017-10-25

  The present invention relates nutritional compositions that can help to reduce glucose peaks in the blood of a subject after consumption of food with a high glycemic index as well as compositions for treatment or prevention of pre-diabetes, diabetes, hyperinsulinemia, hyperglycemia, reduction of glycemic response and metabolic syndrome. The present invention is a composition comprising a synergistic amount of both procyanidins and minerals.

  本发明涉及有助于降低食用高升糖指数食物后受试者血液中葡萄糖峰值的营养组合物，以及用于治疗或预防糖尿病前期、糖尿病、高胰岛素血症、高血糖症、降低血糖反应和代谢综合征的组合物。本发明是一种包含原花青素和矿物质的增效组合物。